Initial evaluation of a patient with suspected prostate cancer includes a detailed history, digital rectal examination, pre-treatment serum prostate-specific antigen (PSA), and Gleason score from the initial prostate biopsy. This evidence concerns the gene KLK3 and prostate carcinoma.